Dale, A
Retatrutide vs Semaglutide: A Research Comparison Retatrutide is a triple GIP/GLP-1/glucagon agonist
Therefore, in the present study, using a segmental osteoperiosteal bone defect (0.8 cm, in the middle of the left radius) that remained incompletely healed in all control rabbits for 6 weeks (assessed in 2-week intervals), pentadecapeptide BPC-157 was further studied (either percutaneously given locally [10 g/kg body weight] into the bone defect, or applied intramuscularly [intermittently, at postoperative days 7, 9, 14, and 16 at 10 g/kg body weight] or continuously [once per day, postoperative days 721 at 10 g or 10 ng/kg body weight])
Men experience similar changes as testosterone declines, though typically at a more gradual pace
It really does seem to have a wide range of healing functions and mechanisms
Summary and Next Steps Daily GHK-Cu injection doses typically range from 1 to 5 mg depending on your goals and individual factors